Physician profile
Jorge E Massare
NPI 1093973661
$66,517.43
in general payments reported to CMS, 2019-2025
34 companies · $19K in 2025
The $19K reported for 2025 was more than what 88% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $7,154 · 2021: $5,927 · 2022: $7,072 · 2023: $4,895 · 2024: $9,787 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,300 · Travel and Lodging: $3,340 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,800.00 |
| Food and Beverage | $10,466.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,300.00 |
| Travel and Lodging | $3,339.69 |
| Education | $116.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $16,650.00 | 2021-2025 | Carto 3 |
| Pfizer INC. | $15,878.97 | 2019-2025 | |
| Biosense Webster, INC. | $9,359.48 | 2019-2025 | Carto 3, Soundstar |
| Medtronic, INC. | $7,211.72 | 2021-2025 | Micra, Pulseselect, Affera Mapping System |
| Medtronic Vascular, INC. | $4,016.15 | 2019-2020 | |
| Abbott Laboratories | $3,818.10 | 2019-2025 | Aveir, Cardiomems, Jot Dx |
| Biotronik INC. | $3,777.14 | 2019-2022 | |
| Boston Scientific Corporation | $1,468.68 | 2019-2025 | Watchman Flx, Watchman Access System, Baylis Medical Company Radiofrequency Puncture Generator |
| Novartis Pharmaceuticals Corporation | $824.45 | 2019-2025 | |
| Itamar Medical INC | $532.55 | 2021-2024 | Watchpatone |
| W. L. Gore & Associates, INC. | $363.52 | 2024-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis |
| Impulse Dynamics (USA) INC. | $327.37 | 2022-2024 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $323.04 | 2021-2025 | Lifevest |
| Irhythm Technologies, INC. | $303.01 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Janssen Pharmaceuticals, INC | $269.97 | 2019-2024 | Xarelto |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $240.18 | 2019-2025 | |
| Philips North America LLC | $195.91 | 2019-2025 | Mcot |
| E.R. Squibb & Sons, L.L.C. | $187.67 | 2019-2025 | Camzyos, Eliquis |
| Zoll Respicardia, INC. | $129.37 | 2021 | |
| Alnylam Pharmaceuticals INC. | $121.13 | 2024 | Onpattro |
| Getinge USA Sales, LLC | $117.08 | 2023 | Acrobat-I Stabilizer |
| Angiodynamics, INC. | $99.98 | 2025 | Auryon Laser System 100-120 Vac |
| Lexicon Pharmaceuticals, INC. | $41.34 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $40.96 | 2023-2024 | Verquvo |
| Terumo Medical Corporation | $32.29 | 2020 | |
| Chiesi USA, INC. | $29.52 | 2022 | |
| Amgen INC. | $28.79 | 2020-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.41 | 2024 | Jardiance |
| Cook Medical LLC | $19.07 | 2020 | |
| Lundbeck LLC | $18.43 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $18.19 | 2022 | |
| Novo Nordisk INC | $17.98 | 2024 | Ozempic, Rybelsus |
| Teleflex LLC | $15.81 | 2020 | |
| Acist Medical Systems, INC. | $14.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Massare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.